arctigenin has been researched along with Myocardial Infarction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Huang, YS; Li, H; Li, Y; Lu, L; Ni, SH; Sun, SN; Wang, JJ; Wang, LJ; Xian, SX; Xiao, W; Yang, ZQ; Zhou, Z | 1 |
Yang, Y; Zhang, Y | 1 |
Cao, YJ; Jiang, YF; Jiang, ZA; Li, YJ; Liu, BY; Song, MC; Sun, JP; Wang, C; Wang, YF; Wang, ZH; Yang, J; Yang, R; Yin, HS | 1 |
3 other study(ies) available for arctigenin and Myocardial Infarction
Article | Year |
---|---|
Arctigenin alleviates myocardial infarction injury through inhibition of the NFAT5-related inflammatory phenotype of cardiac macrophages/monocytes in mice.
Topics: Animals; Furans; Heart; Inflammation; Lignans; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Myocardial Infarction; Myocardium; RAW 264.7 Cells; Signal Transduction; Transcription Factors | 2020 |
Arctigenin exerts protective effects against myocardial infarction via regulation of iNOS, COX‑2, ERK1/2 and HO‑1 in rats.
Topics: Animals; Cyclooxygenase 2; Enzymes; Furans; Gene Expression Regulation; Heme Oxygenase-1; Lignans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; Nitric Oxide Synthase Type II; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley | 2018 |
Arctigenin Attenuates Ischemia/Reperfusion Induced Ventricular Arrhythmias by Decreasing Oxidative Stress in Rats.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Furans; Glutathione Peroxidase; Lignans; Male; Malondialdehyde; Myocardial Infarction; Myocardium; NADPH Oxidase 1; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Thioredoxins | 2018 |